home / stock / nwbo / nwbo quote
Last: | $0.519 |
---|---|
Change Percent: | -3.33% |
Open: | $0.62 |
Close: | $0.519 |
High: | $0.62 |
Low: | $0.5099 |
Volume: | 4,247,677 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.519 | $0.62 | $0.519 | $0.62 | $0.5099 | 4,247,677 | 03-28-2024 |
$0.6 | $0.541 | $0.6 | $0.6489 | $0.5101 | 3,959,506 | 03-27-2024 |
$0.531 | $0.525 | $0.531 | $0.549 | $0.52 | 1,525,172 | 03-26-2024 |
$0.513 | $0.485 | $0.513 | $0.518 | $0.48 | 1,461,676 | 03-25-2024 |
$0.48305 | $0.48 | $0.48305 | $0.4999 | $0.476 | 1,621,580 | 03-22-2024 |
$0.4852 | $0.49 | $0.4852 | $0.49 | $0.471 | 2,349,240 | 03-21-2024 |
$0.488 | $0.51 | $0.488 | $0.52 | $0.481 | 2,492,524 | 03-20-2024 |
$0.506 | $0.52 | $0.506 | $0.53 | $0.4951 | 2,287,597 | 03-19-2024 |
$0.519 | $0.5362 | $0.519 | $0.54 | $0.5111 | 2,292,464 | 03-18-2024 |
$0.53 | $0.53 | $0.53 | $0.5488 | $0.517 | 1,030,511 | 03-15-2024 |
$0.53 | $0.57 | $0.53 | $0.57 | $0.5252 | 1,565,533 | 03-14-2024 |
$0.545 | $0.56 | $0.545 | $0.57 | $0.545 | 1,230,593 | 03-13-2024 |
$0.56 | $0.554 | $0.56 | $0.57 | $0.545 | 1,042,644 | 03-12-2024 |
$0.554 | $0.57 | $0.554 | $0.59 | $0.545 | 1,622,280 | 03-11-2024 |
$0.567 | $0.5731 | $0.567 | $0.584 | $0.56176 | 1,545,484 | 03-08-2024 |
$0.5751 | $0.5766 | $0.5751 | $0.5949 | $0.5731 | 1,344,838 | 03-07-2024 |
$0.5766 | $0.58 | $0.5766 | $0.5894 | $0.5621 | 1,481,407 | 03-06-2024 |
$0.5606 | $0.5788 | $0.5606 | $0.59 | $0.5601 | 1,491,150 | 03-05-2024 |
$0.5788 | $0.5875 | $0.5788 | $0.599 | $0.5633 | 984,506 | 03-04-2024 |
$0.5875 | $0.545 | $0.5875 | $0.59 | $0.545 | 1,323,918 | 03-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
Northwest Biotherapeutics Inc. Company Name:
NWBO Stock Symbol:
OTCMKTS Market:
Northwest Biotherapeutics Inc. Website:
Northwest Biotherapeutics Appoints Seasoned Business Executive and Investor To Its Board of Directors PR Newswire BETHESDA, Md. , March 21, 2024 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax ® ...
Carisma Therapeutics Inc. (CARM) is expected to report $-0.56 for Q4 2023 First Acceptance Corp. (FACO) is expected to report for quarter end 2023-12-31 Bell Copper Corp (BCUFF) is expected to report for quarter end 2023-12-31 BioHarvest Sciences Inc (CNVCF) is expected to report for ...
First Solar Inc. (FSLR) is expected to report $3.19 for Q4 2023 VIZIO Holding Corp. Class A (VZIO) is expected to report $0.02 for Q4 2023 Henry Schein Inc. (HSIC) is expected to report $0.71 for Q4 2023 Republic Services Inc. (RSG) is expected to report $1.28 for Q4 2023 Forge Gl...